1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with mercaptoethanol in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (mercaptoethanol) | Trials (mercaptoethanol) | Recent Studies (post-2010) (mercaptoethanol) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 6,137 | 29 | 279 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camussi, G; Cavalli, PL; Mariano, F; Montrucchio, G; Tetta, C | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and mercaptoethanol
| Article | Year |
|---|---|
Role of alpha 1-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients.
Topics: alpha 1-Antitrypsin; Chromatography, High Pressure Liquid; Humans; Mercaptoethanol; Middle Aged; Osmolar Concentration; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Peritonitis; Platelet Activating Factor; Reference Values; Tumor Necrosis Factor-alpha | 1992 |